Table 1.
Demographics and clinical characteristics of the sample at the time of testing.
| Patients | Controls | |
|---|---|---|
| N | 29 | 32 |
| Gender, female, n | 8 | 20 |
| Age, mean ± SD (year) | 44.31 ± 12.19 | 26.72 ± 9.77 |
| Educational level, mean ± SD (year) | 11.66 ± 2.96 | 16.88 ± 2.31 |
| Handedness, right | 26 | 27 |
| Time since diagnosis, mean ± SD (year) | 18 ± 9.93 | – |
| SANS | ||
| Affective flattening, mean ± SD | 2.86 ± 1.42 | – |
| Alogia, mean ± SD | 2.74 ± 1.31 | – |
| Avolition-Apathy, mean ± SD | 3.16 ± 1.35 | – |
| Anhedonia-Asociality, mean ± SD | 3.34 ± 1.33 | – |
| Attention, mean ± SD | 3.2 ± 1.03 | – |
| SAPS | ||
| Hallucinations, mean ± SD | 1.08 ± 1.14 | – |
| Delusions, mean ± SD | 1.97 ± 1.2 | – |
| Bizarre behavior, mean ± SD | 2.19 ± 1.52 | – |
| Formal thought disorder, mean ± SD | 1.99 ± 1.08 | – |
| Neuroleptics | ||
| First generation, n | 3 | – |
| Second generation, n | 26 | – |
| OLZ equivalents, mean ± SD (mg/day) | 15.89 ± 7.85 | – |